Stock listing
Mangoceuticals, Inc.
Selected listing: MGRX · NASDAQ · USD · US
Mangoceuticals, Inc. (NASDAQ:MGRX), Health Technology. Latest release Oct 1, 2026: Mangoceuticals Secures $2.5 Million Strategic Investment in MangoRx IP…
- Ticker
- NASDAQ:MGRX
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
About Mangoceuticals, Inc.
Mangoceuticals, Inc. (ticker: MGRX) is a public company operating in the American market. Mangoceuticals aims to enhance the quality of life through its offerings.
Latest news from Mangoceuticals, Inc.
Mangoceuticals Secures $2.5 Million Strategic Investment in MangoRx IP Holdings; Receives Initial $1.75 Million Tranche
September 30, 2026
Mangoceuticals Inc.’s Merger Partner, Nuclea Energy, Inc., Enters into Definitive Agreement to Acquire Moltex Energy’s Advanced Nuclear Technology Assets
August 13, 2026
Mangoceuticals’ Merger Partner, Nuclea Energy (“Nuclea”), Executes MOU with Utah Office of Energy Development
August 5, 2026
Mangoceuticals Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement and Comments on Nuclea Energy Business Combination
August 4, 2026
Mangoceuticals Announces Business Combination Agreement with Nuclea Energy Inc. to Advance Next-Generation Nuclear Microreactor Technology
July 30, 2026
Research Mangoceuticals, Inc.
Mangoceuticals, Inc. company profile
View the public company page for Mangoceuticals, Inc. on 6ix.
Mangoceuticals, Inc. news
Read company news and market updates connected to Mangoceuticals, Inc..
Mangoceuticals, Inc. investor events
Find investor webinars, events, and replay context for Mangoceuticals, Inc..